Similar articles for PMID: 19837760

Year	Number of Results
1993	1
1995	3
1996	1
1998	1
1999	1
2000	3
2001	2
2002	2
2003	7
2004	7
2005	5
2006	8
2007	13
2008	14
2009	22
2010	26
2011	32
2012	20
2013	49
2014	30
2015	26
2016	20
2017	25
2018	22
2019	24
2020	13
2021	7
2022	9
2023	8
2024	0

1

18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.

McLarty K, Fasih A, Scollard DA, Done SJ, Vines DC, Green DE, Costantini DL, Reilly RM. McLarty K, et al. J Nucl Med. 2009 Nov;50(11):1848-56. doi: 10.2967/jnumed.109.067231. Epub 2009 Oct 16. J Nucl Med. 2009. PMID: 19837760 Free article.

2

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.

McLarty K, Cornelissen B, Cai Z, Scollard DA, Costantini DL, Done SJ, Reilly RM. McLarty K, et al. J Nucl Med. 2009 Aug;50(8):1340-8. doi: 10.2967/jnumed.109.062224. Epub 2009 Jul 17. J Nucl Med. 2009. PMID: 19617342 Free article.

3

Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.

Razumienko EJ, Scollard DA, Reilly RM. Razumienko EJ, et al. J Nucl Med. 2012 Dec;53(12):1943-50. doi: 10.2967/jnumed.112.106906. Epub 2012 Oct 24. J Nucl Med. 2012. PMID: 23096164 Free article.

4

Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.

Chen P, Cameron R, Wang J, Vallis KA, Reilly RM. Chen P, et al. J Nucl Med. 2003 Sep;44(9):1469-78. J Nucl Med. 2003. PMID: 12960194 Free article.

5

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).

Cornelissen B, McLarty K, Kersemans V, Reilly RM. Cornelissen B, et al. Nucl Med Biol. 2008 Aug;35(6):645-53. doi: 10.1016/j.nucmedbio.2008.05.010. Nucl Med Biol. 2008. PMID: 18678349

6

18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, Van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart M, Flamen P, Di Cosimo S. Gebhart G, et al. J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3. J Nucl Med. 2013. PMID: 24092940 Free article. Clinical Trial.

7

In vivo examination of (188)Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer.

Chen KT, Lee TW, Lo JM. Chen KT, et al. Nucl Med Biol. 2009 May;36(4):355-61. doi: 10.1016/j.nucmedbio.2009.01.006. Epub 2009 Mar 26. Nucl Med Biol. 2009. PMID: 19423002

8

Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET.

Paudyal P, Paudyal B, Hanaoka H, Oriuchi N, Iida Y, Yoshioka H, Tominaga H, Watanabe S, Watanabe S, Ishioka NS, Endo K. Paudyal P, et al. Cancer Sci. 2010 Apr;101(4):1045-50. doi: 10.1111/j.1349-7006.2010.01480.x. Epub 2009 Dec 22. Cancer Sci. 2010. PMID: 20219072 Free article.

9

Tumor uptake and tumor/blood ratios for [⁸⁹Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1.

Al-Saden N, Cai Z, Reilly RM. Al-Saden N, et al. Nucl Med Biol. 2018 Dec;67:43-51. doi: 10.1016/j.nucmedbio.2018.10.002. Epub 2018 Oct 16. Nucl Med Biol. 2018. PMID: 30390575

10

Monitoring Src status after dasatinib treatment in HER2+ breast cancer with ⁸⁹Zr-trastuzumab PET imaging.

McKnight BN, Viola-Villegas NT. McKnight BN, et al. Breast Cancer Res. 2018 Oct 25;20(1):130. doi: 10.1186/s13058-018-1055-2. Breast Cancer Res. 2018. PMID: 30359299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

347 results

Results by year